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Clinical Outcomes
• Primary outcome adherence issues varied by type of 
surgery.
• For hysterectomy, 62 of 141 surgeries (44%) achieved the 
primary outcome. 
o Primary contributor of non-compliance being       
selection of an antibiotic regimen inconsistent with 
system-wide guidelines. 
o Cefazolin monotherapy was considered non-
compliant in the setting of this analysis. If cefazolin
monotherapy was considered compliant, 118/141 
surgeries (84%) would have achieved the primary 
outcome. 
• For colorectal surgeries, 21 of 36 (58%) achieved the 
primary outcome.
o Primary contributor of non-compliance being 
inappropriate antibiotic regimens and dose timing. 
o Additionally, it was identified that history of resistant 
infections may not be accounted for when 
making antibiotic prophylaxis choices, with 3 SSIs 
resulting from multi-drug resistant organisms in 
patients with MDRO history.
• For spinal surgeries, 71 of 147 (48%) achieved the primary 
outcome. 
o Primary contributor of non-compliance being no 
MRSA PCR within the 30 days prior to surgery. 
• For all surgeries, education on true penicillin allergies and 
cross-reactivity rates could provide benefit.
• Allergy regimens given for non-severe allergies:
o Hysterectomy 7 instances
o Colorectal 2 instances
o Spinal 1 instance 
Study Limitations
• Retrospective chart review with select data collected 
manually.
• This data represents a snap-shot in time during a three 
month period.
• Studies estimate surgical site infections (SSIs) 
contribute to ~1 million additional inpatient days per 
year and SSI mortality rate has been estimated to be 
3%. 
• Even a single SSI can have a large impact on a patient 
and institution. The cost of a single SSI is estimated to 
be upward of $25,000 and increases the length of 
hospital stay by ~10 days.
• The Surgical Care Improvement Project (SCIP), a CMS 
program, was initiated in 2006 to provide standard 
quality measures to help reduce SSIs. 
• Advances in infection control practices including 
stricter adherence to antimicrobial prophylaxis after 
the introduction of SCIP has led to a 17% decrease in 
SSIs reported to the NHSN from 2008-2014.
• Although large strides have been made toward 
limiting SSIs, surveillance remains an important 
component for continued reduction. 
• Additionally, this institution has identified 
inappropriate or less than optimal prophylaxis as a 
potential contributor in several SSI cases.
• Recent studies have shown that facility-specific SSI 
monitoring and auditing, as well as pharmacist 
involvement in perioperative antibiotic selection, has 
demonstrated reduction in rates of SSIs.
• Each surgery requires a unique intervention.
• Consistency as an institution regarding surgical antibiotic 
selection is needed and adherence to institutional EPIC 
order sets could improve antibiotic selection. 
• Thorough evaluation of allergy severity may result in less 
allergy regimens (with worse clinical trial outcomes) being 
used. 
• Evaluation of relevant patient history, including history of 
MDROs or MRSA colonization via PCR, may result in more 
optimum choices. 
• PPMC E.Coli susceptibilities are ~88% and may warrant 
alternate antibiotics, in select surgeries, based on surgeon 
discretion. 
Purpose
Hysterectomy 
Health & Services
• This study is a single-center retrospective chart review.
• The study was reviewed and approved by the 
Institutional Review Board (IRB) at our institution.
• Electronic health record (EHR) was used to perform 
chart review and identify the study population.
• Study population:
o Patients who underwent hysterectomy, colorectal,                                                    
or spinal surgery 
• Study period:
o June 1st, 2019 through August 31st, 2019 
• This retrospective analysis aims to review surgical 
antimicrobial prophylaxis for appropriateness based on 
patient-specific factors and hospital system guidelines. 
• Primary outcome: compliance to Providence hospital 
system guidelines. Contributing factors: 
• Opportunities for pharmacist-involvement and education 
were identified for implementation. 
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Colorectal  
Spinal  
Going Forward:
• Cyclic auditing resulted in increased discussion/education.
• Changes still being considered by surgery leadership. 
• Future data collection will be performed once changes are 
implemented to determine improved guideline adherence. 
• Hysterectomy: Cefazolin plus metronidazole 
• Colorectal: Cefazolin plus metronidazole 
• Spinal: Cefazolin if MRSA PCR negative and no history 
of MRSA
o Compliant antibiotic selection
o Compliant antibiotic administration time
o Compliant dosing and re-dosing
Antibiotic Regimen  Colorectal Patients 
(n=36) 
Cefazolin/Metronidazole 22 (60%) 
Piperacillin/Tazobactam 6 (17%) 
Cefazolin  4 (11%) 
Ceftriaxone/Metronidazole 1 (3%) 
Levofloxacin 1 (3%) 
Levofloxacin/Metronidazole 1 (3%) 
Cefazolin/Gentamicin 1 (3%) 
 
Antibiotic Regimen  Hysterectomy 
Patients 
(n=141) 
Cefazolin/Metronidazole 62 (44%) 
Cefazolin  61 (43%) 
Clindamycin/Gentamicin 9 (6%) 
Aztreonam/Clindamycin 3 (2%) 
Clindamycin/Vancomycin 1 (0.7%) 
Cefazolin/Vancomycin 1 (0.7%) 
Metronidazole 1 (0.7%) 
Clindamycin 1 (0.7%) 
Gentamicin 1 (0.7%) 
Ceftriaxone 1 (0.7%) 
 
Hysterectomy 
•N=141
•62 (44%) achieved 
the primary outcome
Colorectal
•N=36
•21 (58%) achieved 
the primary outcome
Spinal
•N=147
•71 (48%) achieved 
the primary outcome
Antibiotic Regimen  Spinal Patients 
(n=147) 
Cefazolin 125 (85%) 
Vancomycin 15 (10%) 
Clindamycin 1 (0.7%) 
Nafcillin 1 (0.7%) 
Ceftriaxone 1 (0.7%) 
MRSA PCR status within 30 days of surgery 
Positive 10 (7%) 
Negative 106 (72%) 
Not obtained 31 (21%) 
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Order Set Preference List
 Hysterectomy 
Patient 
1 
Only allergic to sulfa antibiotics   
Patient 
2 
Penicillin allergy listed as rash, previously 
tolerated piperacillin/tazobactam 
Patient 
3 
Amoxicillin allergy listed as rash  
Patient 
4 
Cefpodoxime allergy listed as rash, 
previously tolerated cefazolin  
Patient 
5 
Penicillin allergy listed as unknown severity, 
previously tolerated cephalexin  
Patient 
6 
Amoxicillin allergy listed as unknown 
severity, previously tolerated cephalexin 
Patient 
7 
Penicillin allergy listed as mild rash  
Colorectal 
Patient 
1 
Penicillin allergy listed was splotches on 
hands  
Patient 
2 
Penicillin allergy of mild severity  
Spinal 
Patient 
1 
Cephalexin allergy listed as rash  
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